Lab result explainedMetabolic panelLast updated November 8, 2026

BNP blood test: what high BNP and NT-proBNP levels mean for your heart

B-type natriuretic peptide (BNP and NT-proBNP) (BNP) · Natriuretic peptide (BNP or NT-proBNP), usually with a basic metabolic panel and troponin · reported in pg/mL (identical to ng/L) for both BNP and NT-proBNP

B-type natriuretic peptide (BNP) is a hormone your heart's pumping chambers release when they are stretched by too much pressure or fluid, and a BNP blood test is the quickest way to tell whether breathlessness, swelling or fatigue is coming from the heart. Labs measure either BNP itself or NT-proBNP, an inactive fragment released at the same time. In someone who arrives breathless, a BNP under 100 pg/mL or an NT-proBNP under 300 pg/mL makes heart failure very unlikely; a BNP over 400 pg/mL, or an NT-proBNP above an age-adjusted cut-off (450 under 50, 900 at 50 to 75, 1,800 over 75), makes it likely.

The higher the number, the more strain the heart is under, and in people with known heart failure the level tracks how well treatment is working and how high the risk of hospital admission is. But BNP is a measure of cardiac stretch, not a diagnosis, and it rises for other reasons: atrial fibrillation, kidney disease, pulmonary embolism, lung disease with strain on the right heart, sepsis, older age and simply being female all push it up. It is also lowered by obesity, which can hide heart failure behind a reassuring result in someone with a body mass index above 35.

Most people reading their result fall into the middle zone, a BNP of 100 to 400 or an NT-proBNP of 300 to 900, where the test alone cannot decide. There, the answer comes from the whole picture: symptoms, examination, an ECG, a chest X-ray and above all an echocardiogram, which shows how the heart is pumping and filling. Outside hospital, where people are usually less unwell, lower cut-offs are used: a BNP under 35 pg/mL or an NT-proBNP under 125 pg/mL in a stable outpatient makes heart failure improbable.

BNP at a glance

  • What it is: a hormone released by the heart's ventricles when they are stretched; it makes the kidneys pass salt and water and relaxes blood vessels. NT-proBNP is the inactive fragment released alongside it.
  • Normal (acute breathlessness): BNP under 100 pg/mL or NT-proBNP under 300 pg/mL makes heart failure unlikely (about 90 to 98 percent of such people do not have it).
  • Likely heart failure: BNP over 400 pg/mL; NT-proBNP over 450 (under 50 years), 900 (50 to 75) or 1,800 pg/mL (over 75). Between these is a grey zone that needs an echocardiogram.
  • Stable outpatient rule-out: BNP under 35 pg/mL or NT-proBNP under 125 pg/mL.
  • Obesity lowers BNP and NT-proBNP by about half, so a body mass index above 35 can hide heart failure; kidney disease, atrial fibrillation and age raise them, so the cut-offs are adjusted.
  • Next step: a high result is read with an ECG, chest X-ray, kidney function and troponin, and confirmed with an echocardiogram; in known heart failure a rising level signals worsening and a fall of more than 30 percent signals response to treatment.

Have your whole report? Paste it into the free Lab Explainer

Every marker explained in plain language, in context with the others, with questions to bring to your appointment. No account needed.

What BNP measures

Heart muscle cells in the ventricles respond to stretch, whether from fluid overload, high filling pressures or a weakened pump, by producing a precursor protein, proBNP. As it is released into the blood this splits into two pieces in equal numbers: BNP, the active hormone, which promotes salt and water loss through the kidneys and relaxes blood vessels, and NT-proBNP, an inactive fragment. Both rise within hours of increased wall stress, so either can be measured. BNP has a half-life of about 20 minutes and NT-proBNP of 60 to 120 minutes, which is why NT-proBNP values run roughly 5 to 10 times higher than BNP for the same degree of heart strain; the two are not interchangeable and the numbers cannot be directly compared.

Because NT-proBNP is cleared mainly by the kidneys, it rises more than BNP when kidney function is poor, and the diagnostic cut-off is raised (to about 1,200 pg/mL in acute breathlessness) when eGFR is below 60. BNP, cleared by receptors and enzymes in tissues including the enzyme neprilysin, is affected by the heart failure drug sacubitril/valsartan (Entresto), which blocks neprilysin and raises BNP while leaving NT-proBNP unchanged; anyone on that drug should be followed with NT-proBNP. Fat tissue clears natriuretic peptides and suppresses their release, so both markers are 30 to 50 percent lower in people with obesity at any given level of heart strain.

Both are measured by immunoassay on a standard blood draw, no fasting needed, with results usually available within an hour in hospital. Different manufacturers' assays give slightly different numbers, so results from different hospitals are compared with caution. Natriuretic peptides vary considerably from week to week in stable patients (by 30 to 50 percent for BNP and about 25 percent for NT-proBNP), so a change has to exceed that before it is read as a real change in heart status. Levels are modestly higher in women and rise steadily with age, which is why NT-proBNP cut-offs are age-adjusted.

Normal range for BNP

Reference ranges vary between labs and by age, sex and pregnancy. Use the range printed on your own report.

GroupTypical range (pg/mL (identical to ng/L) for both BNP and NT-proBNP)Notes
BNP, heart failure unlikely (acute breathlessness)Below 100 pg/mLNegative predictive value about 90 percent in the Breathing Not Properly study. Some labs quote a 'normal' upper limit near 100 pg/mL; others print age- and sex-specific intervals.
BNP, grey zone100–400 pg/mLHeart failure possible; also typical of atrial fibrillation, kidney disease, lung disease with right-heart strain, pulmonary embolism and older age. An echocardiogram decides.
BNP, heart failure likelyAbove 400 pg/mLPositive predictive value above 90 percent in acute breathlessness. Values above 1,000 pg/mL indicate severe decompensation and a higher short-term risk.
NT-proBNP, heart failure unlikely (acute breathlessness)Below 300 pg/mLNegative predictive value about 98 percent at any age (ICON pooled analysis).
NT-proBNP, heart failure likely, by ageAbove 450 pg/mL under 50; above 900 at 50–75; above 1,800 pg/mL over 75Age-stratified rule-in cut-offs from the PRIDE and ICON studies, about 90 percent sensitive and 84 percent specific overall. With eGFR below 60 a single cut-off of about 1,200 pg/mL is used.
Stable outpatient (non-acute) rule-outBNP below 35 pg/mL; NT-proBNP below 125 pg/mLRecommended by the 2021 European and 2022 US heart failure guidelines to decide who needs an echocardiogram when symptoms develop gradually.
Obesity (BMI 35 or more)Levels about half those expectedSome clinicians halve the cut-offs (for example BNP 50 instead of 100). A 'normal' result in someone with severe obesity does not exclude heart failure.
Prognosis in known heart failureNT-proBNP persistently above about 1,000 pg/mL, or BNP above 400–500, marks higher riskA fall of 30 percent or more during hospital treatment, or an NT-proBNP below 1,000 at discharge, predicts fewer readmissions. Levels above 5,000 pg/mL carry a high one-year risk.

High BNP or NT-proBNP

A high BNP or NT-proBNP means the walls of your heart's ventricles are being stretched more than normal and are signalling for help. The most common reason is heart failure: either the pump has weakened (reduced ejection fraction) or the muscle has stiffened and cannot fill properly (preserved ejection fraction), and in both cases pressure backs up into the lungs and veins. The size of the rise matters. In a breathless patient a BNP above 400 or an NT-proBNP above the age-adjusted cut-off is strong evidence for heart failure; a BNP above 1,000 or NT-proBNP above 5,000 indicates severe strain. Levels with preserved ejection fraction tend to be lower, sometimes within the grey zone, so a moderate result does not mean a milder problem.

Many other conditions stretch or stress the ventricles and raise the level without heart failure being the diagnosis. Atrial fibrillation alone commonly produces a BNP of 100 to 300. A pulmonary embolism, pneumonia with low oxygen, COPD or pulmonary hypertension strains the right ventricle. A heart attack, myocarditis, severe aortic or mitral valve disease, a thickened heart muscle from long-standing high blood pressure, and the fluid shifts of sepsis, cirrhosis or chronic kidney disease all push it up. Kidney disease matters twice: it raises filling pressures and, for NT-proBNP in particular, slows clearance, so a moderately raised level in someone with an eGFR under 60 is read against higher cut-offs.

For someone already diagnosed with heart failure, the number is a running gauge of how compensated the heart is. A level that is stable and low, ideally an NT-proBNP under 1,000 pg/mL, goes with a good outlook; a rise of more than about 30 to 50 percent from your usual value, especially with weight gain, breathlessness or swelling, means fluid is accumulating and treatment needs adjusting before it becomes an admission. Trials of adjusting drugs purely to hit a BNP target have not shown clear benefit over good symptom-guided care, so the number informs treatment rather than dictating it.

Common causes

  1. Heart failure with reduced or preserved ejection fraction

    The main cause. A weakened or stiff left ventricle raises filling pressure and wall stress, releasing BNP in proportion to severity. Values are highest in acute decompensation and in reduced ejection fraction; preserved ejection fraction, particularly with obesity, can produce only a modest rise.

  2. Atrial fibrillation and other arrhythmias

    Fast or irregular rhythms raise atrial and ventricular pressures; atrial fibrillation on its own typically lifts BNP to 100 to 300 pg/mL and NT-proBNP to 500 to 1,500, overlapping the heart failure range.

  3. Heart attack and acute coronary syndrome

    Ischemic muscle stretches and releases BNP within hours; the level after a heart attack predicts later heart failure and mortality even when the pump looks good.

  4. Chronic kidney disease

    Fluid retention, high blood pressure and heart muscle changes raise production, and reduced kidney clearance raises NT-proBNP further; at an eGFR below 60 the NT-proBNP rule-in threshold rises to about 1,200 pg/mL and the BNP threshold to about 200.

  5. Pulmonary embolism, pulmonary hypertension, COPD and sleep apnea

    Anything that raises pressure in the lung circulation strains the right ventricle, which also releases BNP. In pulmonary embolism a raised BNP marks right-heart strain and a higher-risk clot.

  6. Valve disease and cardiomyopathy

    Severe aortic stenosis, mitral or aortic regurgitation, hypertrophic cardiomyopathy and infiltrative diseases such as cardiac amyloidosis all raise BNP, sometimes to very high levels; a high BNP in aortic stenosis is one of the triggers for considering valve replacement.

  7. High blood pressure with left ventricular hypertrophy

    Years of high pressure thicken and stiffen the heart muscle, raising filling pressures. The level falls as blood pressure is controlled and the thickening regresses.

  8. Sepsis, severe illness, anemia and hyperthyroidism

    Critical illness, severe anemia and an overactive thyroid increase cardiac output and wall stress and directly stimulate BNP release; levels of several hundred are common in intensive care without primary heart disease.

  9. Older age and female sex

    Both raise baseline BNP and NT-proBNP, which is why NT-proBNP rule-in cut-offs quadruple between the under-50s and the over-75s. A healthy 80-year-old woman may have an NT-proBNP of 200 to 400 pg/mL.

  10. Sacubitril/valsartan (BNP only)

    This heart failure drug blocks neprilysin, the enzyme that breaks down BNP, so BNP rises by 20 to 50 percent on treatment even as the heart improves. NT-proBNP is unaffected and should be used for monitoring instead.

Symptoms that can go with it

  • Breathlessness on exertion, then at rest; needing extra pillows at night or waking breathless (orthopnea and paroxysmal nocturnal dyspnea)
  • Swelling of the ankles, legs and abdomen; rapid weight gain of 2 to 3 lb in a day or 5 lb in a week from fluid
  • Fatigue, weakness and reduced ability to exercise
  • A persistent cough or wheeze, sometimes with frothy or pink-tinged sputum
  • Palpitations or an irregular heartbeat, which may point to atrial fibrillation
  • Loss of appetite, nausea and abdominal bloating from congestion of the liver and gut
  • Chest pain or pressure, which with a high BNP raises concern about a heart attack or pulmonary embolism
  • Often none in mild chronic heart failure or in a raised level caused by kidney disease or age

Low or normal BNP

A low BNP or NT-proBNP is a reassuring result. In someone with breathlessness, a BNP under 100 pg/mL or an NT-proBNP under 300 pg/mL means heart failure is very unlikely (only about 2 to 10 percent of such people turn out to have it), and attention turns to lungs, anemia, deconditioning, anxiety or other causes. In a stable outpatient, values under 35 and 125 pg/mL respectively usually mean an echocardiogram can be avoided. There is no lower limit of concern: healthy young adults commonly have a BNP under 20 and an NT-proBNP under 50 pg/mL, and a low value on treatment for heart failure is a sign the treatment is working.

A normal result does not exclude every heart problem, however. Obesity suppresses natriuretic peptides by around half, so heart failure in someone with a body mass index over 35 can hide behind a BNP of 60 or 80. Heart failure with preserved ejection fraction produces lower values and up to a fifth of patients with it have an NT-proBNP in the 'normal' range, especially when obese. Flash pulmonary edema can present before the level has had time to rise, and conditions where the ventricle is not stretched, such as mitral stenosis, constrictive pericarditis or a pericardial effusion, cause congestion with a deceptively modest BNP. When symptoms strongly suggest heart failure, an echocardiogram is done regardless of the number.

Common causes

  1. A healthy heart

    The expected finding. Without stretch on the ventricles, production is minimal; most adults under 50 have a BNP below 30 and an NT-proBNP below 100 pg/mL.

  2. Obesity

    Fat tissue carries receptors that clear natriuretic peptides and secretes signals that suppress their release, lowering BNP and NT-proBNP by 30 to 50 percent at a body mass index above 30 to 35; the suppression can mask genuine heart failure.

  3. Effective heart failure treatment

    Diuretics, ACE inhibitors, ARBs, beta-blockers, mineralocorticoid antagonists and SGLT2 inhibitors all lower filling pressures and BNP; a fall of 30 percent or more during admission predicts fewer readmissions.

  4. Heart failure with preserved ejection fraction, particularly in obesity

    Because the ventricle is thick-walled and not dilated, wall stress and BNP release are lower for the same pressure; 15 to 20 percent of patients with preserved ejection fraction have NT-proBNP below the diagnostic cut-off.

  5. Very early or 'flash' pulmonary edema

    BNP takes a few hours to rise, so a sample drawn in the first hour of a sudden episode can be normal despite fluid in the lungs; a repeat is informative.

  6. Congestion without ventricular stretch

    Mitral stenosis, constrictive pericarditis, cardiac tamponade and some cases of acute mitral regurgitation back fluid up without stretching the ventricle, so BNP is modest despite serious disease.

Symptoms that can go with it

  • None; a low BNP does not cause symptoms
  • If you are breathless with a normal BNP, the cause still needs finding: asthma, COPD, pneumonia, anemia, pulmonary embolism, deconditioning or anxiety are common explanations
  • Breathlessness or swelling with a normal BNP in someone with a body mass index above 35 should still prompt an echocardiogram
  • Sudden severe breathlessness with a normal first BNP can still be flash pulmonary edema; symptoms that persist warrant a repeat test a few hours later
  • Swelling, raised neck veins and fatigue with a modest BNP can occur in constrictive pericarditis or mitral stenosis, where the ventricle is not stretched

Read it alongside

  • Troponin — rises with heart muscle injury; a high BNP with a high troponin points to a heart attack, myocarditis or pulmonary embolism rather than simple congestion.
  • Creatinine and eGFR — kidney function changes how the result is read (NT-proBNP cut-off rises to about 1,200 pg/mL when eGFR is below 60) and guides diuretic dosing.
  • Sodium and potassium — low sodium in heart failure marks severity and a worse outlook; potassium guides the safety of ACE inhibitors, ARBs and mineralocorticoid antagonists.
  • Hemoglobin — anemia raises BNP and worsens heart failure symptoms; correcting iron deficiency improves symptoms in heart failure trials.
  • TSH — both an overactive and an underactive thyroid can cause or worsen heart failure and raise BNP.
  • Albumin and liver enzymes — low albumin worsens edema; raised liver enzymes and bilirubin reflect congestion of the liver in right-sided failure.
  • Chest X-ray and ECG — not blood tests but always read alongside: fluid in the lungs, an enlarged heart, atrial fibrillation or evidence of a previous heart attack change what a borderline BNP means.
  • Echocardiogram — the test that confirms or excludes heart failure and shows the type; a grey-zone BNP is almost always followed by one.

What usually happens next

  1. A high result in someone who is breathless is usually followed the same day by an ECG, chest X-ray, troponin, kidney function and an echocardiogram to confirm heart failure and find the cause (weak pump, stiff pump, valve disease, rhythm problem or a recent heart attack).
  2. A grey-zone result (BNP 100 to 400, NT-proBNP 300 to the age cut-off) is interpreted with body mass index, kidney function, heart rhythm and age; an echocardiogram is the usual next step rather than a repeat blood test.
  3. If heart failure is confirmed, expect treatment to begin and a repeat level in 2 to 4 weeks and after any change in medication; a fall of 30 percent or more indicates response.
  4. Ask what your own baseline is once you are stable; a rise of more than about 30 to 50 percent from baseline, or above 1,000 pg/mL NT-proBNP, together with weight gain or swelling, is a reason to contact your clinic early.
  5. If you take sacubitril/valsartan, ask that NT-proBNP rather than BNP is used for monitoring, since the drug raises BNP artificially.
  6. A normal result with ongoing breathlessness redirects the work-up to lungs, anemia, thyroid, fitness and anxiety; if you have severe obesity and symptoms strongly suggest heart failure, an echocardiogram is still appropriate.

Diet, lifestyle and natural levers with evidence

What can move BNP once the cause is known. Nothing here replaces finding the cause.

Controlling blood pressure

Strong evidence

High blood pressure is the leading preventable cause of heart failure, and lowering it lowers natriuretic peptides by reducing wall stress and reversing muscle thickening. In the SPRINT trial, treating systolic pressure to a target of 120 rather than 140 mmHg cut new heart failure by 38 percent, and in the LIFE study a fall in NT-proBNP with antihypertensive treatment tracked regression of left ventricular hypertrophy and fewer cardiovascular events. Diet (DASH), weight, alcohol, sodium and medication all contribute.

Supervised exercise training and cardiac rehabilitation

Moderate evidence

An individual-patient meta-analysis of 10 randomised trials in people with heart failure found that 3 to 6 months of aerobic training lowered BNP by about 28 percent and NT-proBNP by about 37 percent compared with usual care, alongside better exercise capacity and quality of life. The large HF-ACTION trial showed exercise training was safe and modestly reduced hospitalisation and death once adherence was accounted for. Programmes typically start at 20 to 30 minutes of moderate activity three times a week under supervision.

Exercise in heart failure should begin after a clinical assessment and ideally in a cardiac rehabilitation programme; stop and seek help for chest pain, dizziness or breathlessness out of proportion to effort.

Moderating sodium and tracking fluid

Moderate evidence

Sodium drives fluid retention, which raises filling pressures and BNP, and US and European guidelines advise avoiding excessive intake (above about 2 to 3 g of sodium a day) in heart failure. The SODIUM-HF trial of 806 patients found that a strict target under 1,500 mg a day for a year did not reduce deaths or admissions compared with usual advice, though quality of life and symptom class improved modestly, so very strict restriction is not required and moderation is the realistic target. Daily weighing to catch fluid gain early (2 to 3 lb in a day or 5 lb in a week) is standard self-care.

Sodium restriction combined with high-dose diuretics can cause low sodium and dehydration, particularly in older adults; fluid restriction is only advised when sodium is low or congestion is severe.

Limiting alcohol

Moderate evidence

Heavy drinking weakens heart muscle directly (alcoholic cardiomyopathy) and triggers atrial fibrillation, both of which raise BNP. Abstinence improves ejection fraction in alcoholic cardiomyopathy in observational series, and in a randomised trial of 140 regular drinkers with atrial fibrillation, cutting intake from about 17 to 2 drinks a week reduced recurrence of the arrhythmia from 73 to 53 percent over six months. Guidelines advise no more than one drink a day for women and two for men, and none in alcohol-related cardiomyopathy.

Treating obstructive sleep apnea

Preliminary evidence

Obstructive sleep apnea is present in a third to a half of people with heart failure and raises nocturnal blood pressure, right-heart strain and BNP. Small randomised trials of CPAP in heart failure patients with sleep apnea improved ejection fraction by 5 to 9 percentage points and lowered blood pressure and sympathetic activity, with reductions in BNP of 20 to 40 percent in some but not all studies. CPAP is not recommended for central sleep apnea with reduced ejection fraction (the SERVE-HF trial of adaptive servo-ventilation found harm), so the type of apnea matters.

Coenzyme Q10

Preliminary evidence

In the Q-SYMBIO trial, 420 people with moderate to severe heart failure randomised to 300 mg of coenzyme Q10 a day or placebo for two years had fewer major cardiovascular events (15 versus 26 percent) and lower mortality, but NT-proBNP did not fall significantly compared with placebo, and ejection fraction was unchanged. A meta-analysis of smaller trials suggests modest improvements in ejection fraction. It is reasonable as an add-on but does not replace guideline treatment.

Can reduce the effect of warfarin; discuss if you take an anticoagulant. Choose a product tested by an independent laboratory, as supplement quality varies.

When to see a clinician promptly

  • Severe breathlessness at rest, breathlessness that wakes you or stops you lying flat, or frothy or pink sputum: call emergency services, since this may be acute pulmonary edema.
  • Chest pain or pressure, fainting, or a very fast or irregular heartbeat with a high BNP: emergency assessment for heart attack, pulmonary embolism or a dangerous rhythm.
  • A BNP above 400 pg/mL or NT-proBNP above the age cut-off (450, 900 or 1,800) with any new breathlessness, swelling or fatigue: same-day or next-day assessment and an echocardiogram.
  • In known heart failure: weight gain of 2 to 3 lb in a day or 5 lb in a week, worsening swelling or needing more pillows, or a BNP that has risen more than 30 to 50 percent from your usual value.
  • New confusion, very low urine output, cold clammy skin or a systolic blood pressure under 90 mmHg in someone with heart failure, which can indicate the heart is failing to maintain circulation.
  • A grey-zone BNP (100 to 400 pg/mL) that has not been followed by an echocardiogram, particularly if you are over 65, have atrial fibrillation, kidney disease, high blood pressure or diabetes.

Frequently asked questions

What is a normal BNP level?

In someone with breathlessness, a BNP under 100 pg/mL makes heart failure unlikely and most healthy adults under 50 have a BNP below 30. For NT-proBNP, under 300 pg/mL rules heart failure out in the acute setting, and healthy adults typically run under 125, rising with age so that a healthy 80-year-old may have 200 to 400. For stable outpatients with gradual symptoms, lower cut-offs are used: BNP under 35 or NT-proBNP under 125 pg/mL. Labs differ slightly, so check the interval on your report.

Is a BNP of 400 high?

Yes. A BNP of 400 pg/mL is the threshold above which heart failure becomes the likely explanation for breathlessness, with a positive predictive value above 90 percent. It needs an echocardiogram and a review of kidney function, heart rhythm and blood pressure. A BNP of 400 can also occur in atrial fibrillation, kidney disease or pulmonary embolism, so it is a strong signal rather than a diagnosis on its own.

What is the difference between BNP and NT-proBNP?

Both come from the same precursor protein released by stretched heart muscle and are released in equal amounts. BNP is the active hormone and lasts about 20 minutes in the blood; NT-proBNP is an inactive fragment that lasts one to two hours, so its numbers run five to ten times higher. They give the same clinical information but the cut-offs differ (100 and 400 for BNP versus 300 and 450 to 1,800 for NT-proBNP), NT-proBNP rises more with kidney disease, and only BNP is raised by the drug sacubitril/valsartan.

What BNP level indicates heart failure?

In acute breathlessness, a BNP above 400 pg/mL or an NT-proBNP above 450 (under 50), 900 (50 to 75) or 1,800 pg/mL (over 75) indicates heart failure is likely; below 100 and 300 respectively it is unlikely. Values between are a grey zone where about a third to a half of people have heart failure and an echocardiogram is needed. In someone already diagnosed, the level that indicates trouble is a rise of more than 30 to 50 percent from their own stable baseline.

Can BNP be high without heart failure?

Yes, often. Atrial fibrillation, chronic kidney disease, pulmonary embolism, pneumonia, COPD with strain on the right heart, pulmonary hypertension, a heart attack, severe valve disease, sepsis, severe anemia, an overactive thyroid and simply being older or female all raise BNP, usually into the 100 to 400 range. Very high values (BNP above 1,000, NT-proBNP above 5,000) are rarely explained by anything other than heart strain or advanced kidney disease.

Does obesity affect BNP levels?

Yes, it lowers them. Fat tissue clears natriuretic peptides and suppresses their release, so BNP and NT-proBNP are 30 to 50 percent lower in people with a body mass index above 30 to 35 for the same degree of heart strain. Some clinicians halve the cut-offs in severe obesity, and a 'normal' result should not be used to rule out heart failure in a severely obese person whose symptoms suggest it; an echocardiogram is done instead. Weight loss, paradoxically, raises BNP toward normal even as the heart improves.

How can I lower my BNP levels?

BNP falls when the strain on the heart falls, so the answer is treating the cause: guideline heart failure medicines (ACE inhibitors or ARBs or sacubitril/valsartan, beta-blockers, mineralocorticoid antagonists, SGLT2 inhibitors and diuretics as needed), controlling blood pressure and heart rhythm, and treating valve disease or ischemia. Supervised exercise training lowered NT-proBNP by about a third in trials, moderating sodium and alcohol and treating sleep apnea help, and daily weighing catches fluid early. Supplements do not reliably lower BNP; coenzyme Q10 improved outcomes in one trial without changing NT-proBNP.

What is a dangerously high BNP level?

There is no single danger number, because the level depends on age, kidney function and body size, but a BNP above 1,000 pg/mL or an NT-proBNP above 5,000 pg/mL in a breathless person indicates severe decompensation and a high short-term risk, and such values are usually managed in hospital. In chronic heart failure, an NT-proBNP that stays above about 1,000 pg/mL despite treatment marks a higher risk of admission and death and often prompts intensification of therapy or referral to a specialist clinic.

References

  1. Natriuretic peptide tests (BNP, NT-proBNP). MedlinePlus, US National Library of Medicine (2023)View source
  2. Maisel AS, Krishnaswamy P, Nowak RM, et al.. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine (2002)
  3. Januzzi JL, van Kimmenade R, Lainchbury J, et al.. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients (ICON). European Heart Journal (2006)
  4. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al.. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Journal of the American College of Cardiology (2006)
  5. Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA/ACC/HFSA guideline for the management of heart failure. Circulation (2022)
  6. McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal (2021)
  7. Mueller C, McDonald K, de Boer RA, et al.. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. European Journal of Heart Failure (2019)
  8. Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. International Journal of Cardiology (2014)
  9. Felker GM, Anstrom KJ, Adams KF, et al.. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial (GUIDE-IT). JAMA (2017)
  10. Smart NA, Meyer T, Butterfield JA, et al.. Individual patient meta-analysis of exercise training effects on systemic brain natriuretic peptide expression in heart failure. European Journal of Preventive Cardiology (2012)
  11. Ezekowitz JA, Colin-Ramirez E, Ross H, et al.. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet (2022)
  12. Mortensen SA, Rosenfeldt F, Kumar A, et al.. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO, a randomized double-blind trial. JACC: Heart Failure (2014)

Related markers

Related conditions

Evidence guides

Worried about your number?

Ask AskMN what your BNP result could mean in the context of your other results, symptoms and medications. Free, unlimited, no account needed.

Ask about my BNP

This page is educational and is not medical advice or a diagnosis. Lab results have to be interpreted together with your history, symptoms and other results by a clinician who knows you. Do not start or stop a supplement to change a lab value before the cause is known.